Back to top
more

Omnicell (OMCL)

(Delayed Data from NSDQ)

$50.14 USD

50.14
466,690

-2.32 (-4.42%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $50.16 +0.02 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 250)

Industry: Medical Info Systems

Zacks News

Omnicell (OMCL) Reports Next Week: Wall Street Expects Earnings Growth

Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Omnicell (OMCL) Soars to 52-Week High, Time to Cash Out?

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?

Style Box ETF report for SLYG

Quest Diagnostics (DGX) Q3 Earnings Top Estimates, View Up

Quest Diagnostics (DGX) notes that in late summer it experienced some softness in the base business across the country but recovered in September.

Abbott's (ABT) Q3 Earnings Beat Estimates, 2021 Guidance Up

Abbott's (ABT) COVID-19 testing-related sales in Q3 increase on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.

Intuitive Surgical (ISRG) Q3 Earnings Match Estimates, Up Y/Y

Intuitive Surgical's (ISRG) third-quarter results reflect strong segmental performance.

CNVY vs. OMCL: Which Stock Should Value Investors Buy Now?

CNVY vs. OMCL: Which Stock Is the Better Value Option?

Walgreens Boots (WBA) Q4 Earnings Top Estimates, Margins Up

Walgreens Boots' (WBA) health and wellness sales increase for fiscal Q4 on growing demand for at-home COVID-19 tests and vitamins.

Should Vanguard S&P SmallCap 600 Growth ETF (VIOG) Be on Your Investing Radar?

Style Box ETF report for VIOG

Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?

Style Box ETF report for SPSM

Quidel Corporation (QDEL) Reports Solid Preliminary Q3 Revenues

Quidel's (QDEL) revenue growth in the third quarter is likely to have been boosted by robust sales of its SARS-related products.

Catalent (CTLT) Expands Presence in Japan Via New Facility

Catalent's (CTLT) new site is expected to become a key hub in its Asia-Pacific Clinical Supply Services network by significantly boosting its business.

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Zacks Industry Outlook Highlights: 10x Genomics, Omnicell, Inspire Medical Systems and Cerner

Here's Why You Should Add DexCom (DXCM) Stock to Your Portfolio

Investors continue to be optimistic about DexCom (DXCM) owing to its slew of favorable coverage decisions for its G6 CGM System.

Urmimala Biswas headshot

Buy 3 Medical Info Systems Stocks to Brave Industry-wide Challenges

Stocks like 10x Genomics Inc. (TXG), Omnicell, Inc. (OMCL) and Inspire Medical Systems, Inc. (INSP) are expected to gain despite pandemic-led disruptions.

Here's Why You Should Retain Merit Medical (MMSI) Stock For Now

Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.

Omnicell (OMCL) Soars to 52-Week High, Time to Cash Out?

Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Omnicell (OMCL) Soars 3.4%: Is Further Upside Left in the Stock?

Omnicell (OMCL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

AMN Healthcare (AMN) Hits 52-Week High: What's Behind It?

Investors are optimistic about AMN Healthcare's (AMN) broad array of services.

Surmodics' (SRDX) Latest Sublime Catheter Expands Patient Pool

Surmodics' (SRDX) latest addition is expected to aid in performing more complex interventions which were earlier not possible.

Dexcom's (DXCM) G6 CGM System Gets Coverage in Manitoba

Dexcom's (DXCM) CGM System is expected to simplify diabetes management due to increasing access to the life changing technology.

Reasons to Hold on to Inari Medical (NARI) Stock For Now

Investors continue to be optimistic about Inari Medical (NARI) owing to its focus on understanding the venous system and its commitment toward patient care.

Urmimala Biswas headshot

3 Sectors Looking Up Ahead of Q3 Earnings Despite COVID-19 Woes

There has been notable job gains in automotive, hospitality, retail, social assistance and in professional and business services through the past few months.

AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates

AngioDynamics (ANGO) registers strong revenue growth across the majority of its GBUs as well as in domestic revenues in fiscal 2022 Q1.